Abstract: Autoantibodies against particular nuclear components, such as chromatin and snRNPs, are a characteristic feature of the autoimmune disease systemic lupus erythematosus. The last decade, evidence has suggested that apoptotic cells are the main source of autoantigens in this disease. Therefore, it has been proposed that protein modifications occurring during apoptosis lead to the formation of neo-epitopes, which can break the tolerance when apoptotic cells are not properly cleared. Indeed, many lupus autoantigens are prone to apoptosis-associated post-translational modifications and/or cleavage by caspases. In addition, lupus autoantigens are relocated from the nucleus to apoptotic blebs on the cell surface of early apoptotic cells. Therefore, to understand why certain nuclear proteins become autoantigens during apoptosis, it is important to know the apoptotic processing of these proteins. This review summarizes the current knowledge of apoptotic processing of lupus autoantigens and the possible effects on their encounter with the immune system in normal and autoimmune situations.
Introduction
Many cells die each day in our body to establish tissue homeostasis, to remove unwanted immune cells, in development or during infections. Several tightly regulated pathways, called apoptosis, have evolved to ensure the disposal of dying cells and their debris as silent as possible without activating the immune system [1] . In contrast, necrosis is primarily considered as a non-silent pathway of cell death, which is supposed to activate the immune system. Apoptosis can be induced by different pathways, but finally all these pathways lead to the same result: the coordinated breakdown of cellular structures, of which the nucleus is the most striking [2] . Therefore, nuclear changes have been considered as the best applicable and most specific marker for apoptosis [3] . The nuclear changes include the condensation and fragmentation of chromatin and the clustering of many other nuclear components into so-called heterogeneous ectopic RNP-derived structures (HERDS) [4] . Another feature of apoptosis, and not necrosis, is the appearance of many blebs on the cell surface, which contain cytoplasmic and nuclear components [5] . Both the nuclear changes and the appearance of surface blebs are early features of apoptosis, although their function is still unclear [2] .
The autoimmune disease systemic lupus erythematosus (SLE) is characterized by autoantibodies directed mainly against nuclear structures [6, 7] . The apoptotic cell has been proposed as the source of nuclear autoantigens targeted during lupus, since (i) nuclear autoantigens were identified in apoptotic surface blebs [8] ; (ii) mice deficient in molecules involved in the removal of apoptotic cells develop lupus-like autoimmunity [9, 10] ; (iii) apoptotic cells, especially in combination with dendritic cells (DCs) are able to activate autoreactive T cells and induce an anti-nuclear immune response in mice [11] [12] [13] ; and (iv) autoantibodies from lupus patients and mice preferably recognize modified proteins from apoptotic cells [14] [15] [16] [17] [18] [19] [20] .
function by changing for instance the interaction with other proteins, the activity and/or the stability. Therefore, it is logical that apoptosis involves the modification of many proteins. Early during apoptosis nuclear processes, such as transcription and mRNA splicing, have to be deviated to transcribe genes encoding proapoptotic proteins [21] , and finally these processes are fully terminated [2] . Post-translational modifications of histones have an essential function in the regulation of chromatin structure and gene transcription [22] . Indeed, changes in the post-translational modifications of histones have been identified in chromatin from apoptotic cells. Thus, histone H2B is phosphorylated on Ser14 during apoptosis [23] , which has been associated with the condensation of chromatin [24] . In addition, changes in the acetylation of histones H2A, H3 and H4 occur during apoptosis [19, [25] [26] [27] [28] . In different cell lines, using different apoptosis inducers, both apoptosis-associated acetylation and deacetylation of histones have been found. Interestingly, acetylated histone H4 is an important target of autoantibodies from lupus mice and patients [19] . In addition, injection of a H4 peptide acetylated on Lys8, 12 and 16 aggravated disease symptoms in lupus mice, whereas the non-acetylated H4 peptide showed no effect. A (pre-apoptotic) difference in the acetylation and methylation of histones was found in splenocytes form lupus mice compared to control mice [29] . Ubiquitinated H2A was identified as a target for lupus autoantibodies [30, 31] , however, so far only deubiquitination of histone H2A has been associated with apoptosis [32] . Dephosphorylation and poly(ADP)-ribosylation of histone H1 and phosphorylation of histone H2A, H2A.X and H3 have also associated with apoptosis [33] [34] [35] [36] . Finally, transglutamination of histone H2B during apoptosis was found [37] and transglutamination was proposed to prevent the leakage of proteins from apoptotic cells [38] . Many other possible histone modifications have not been studied in association with apoptosis, whereas most modified histones have not been tested with autoantibodies from lupus mice and patients. In addition, modifications of DNA, such oxidation or methylation, can occur and might change the immunogenicity of DNA.
Modifications of RNA-associated proteins (RNPs) have been associated with the regulation of mRNA transcription and splicing [39] . Particularly, changes in the phosphorylation have been associated with apoptosis. SR proteins, which are important regulators of mRNA splicing, are dephosphorylated during Fas-induced apoptosis by protein phosphatase 1 [40] . Dephosphorylated SR proteins are specifically recognized by lupus autoantibodies [41] . Phosphorylated RNA polymerase II was one of the first identified modified targets of lupus autoantibodies [42, 43] , however, changes in the phosphorylation state of RNA polymerase II, which determine its activity, have not been associated with apoptosis so far [44] . In addition, changes in the methylation level of Sm snRNPs have not been identified yet during apoptosis, while symmetrically-dimethylated arginine residues in the C-terminal tails of SmD1, D3 and BB' proteins are recognized by lupus autoantibodies [45] . Probably, the most striking modified lupus autoantigens associated with apoptosis is the spliceosomal U1-70K snRNP. The U1-70K protein is one of the U1 snRNP-specific proteins of the U1 snRNP particle and plays an important role in the recognition of 5' splice sites on mRNA. Several reports have described that the apoptotic 40-kDa fragment of the U1-70K protein generated after caspase cleavage is much better recognized in denatured conditions by autoantibodies from lupus mice and patients [16] [17] [18] . We have recently described that during apoptosis a specific change in the phosphorylation status of the U1-70K protein occurs (Fig. 1) [20] . First, the phosphorylation of Ser140 in the RNA recognition motif (RRM) increases directly after the induction of apoptosis. Then, simultaneously with the cleavage by caspase-3, a caspase-dependent dephosphorylation by protein phosphatase 1 of other residues in the U1-70K protein takes place. Interestingly, a peptide comprised of a sequence of the RNA binding domain including the phosphorylated Ser140, is recognized by autoreactive T cells [46] .
In addition to post-translational modification, cleavage by proteases, such as caspases and granzymes, of many nuclear proteins occurs. Cleavage can affect the recognition of the affected protein by lupus autoantibodies [47] .
Relocation of nuclear proteins
Morphological changes of the nucleus are considered to be a specific feature of apoptosis. Condensation and fragmentation of chromatin is a well-studied process [48] ; however, many parts of this mechanism remain elusive. Caspases activate DNA cleaving enzymes such as caspase activated DNase (CAD) [49] . In addition, proteins such as the apoptosis-inducing factor (AIF) are translocated from mitochondria to the nucleus [50] . Both CAD and AIF are essential for the condensation of chromatin, although for different stages. In addition, the condensation of chromatin is associated with several modifications of histones (as described above). Some changes in the structure of chromatin might also result in the exposure of neo-epitopes. During the condensation and under the control of several DNases, chromatin starts to fragment [49] . This fragmentation results finallyin the release of small chromatin particles during late apoptosis (also called secondary necrosis). These chromatin particles are able to stimulate the immune system if they are bound to anti-chromatin autoantibodies [51] . Released chromatin particles have been found to contain HMGB1, a classical example of a damage-associated molecular pattern (DAMP) or alarmin [52] . HMGB1-containing chromatin can stimulate the immune system and has been identified in the circulation of lupus patients [52, 53] .
While the chromatin condenses, other nuclear structures relocate into HERDS, which were described for the first time in a paper by Biggiogera et al. [54, reviewed in refs 4 and 55] . Early during apoptosis structures normally present in the interchromatin space, such as the interchromatin granules (also called nuclear speckles), perichromatin fibrils (sites of transcription) and perichromatin granules cluster together in HERDS. This clustering continues with the addition of domains of the nucleolus, which probably makes this process irreversible [4] . HERDS are based on structures, such as the interchromatin granules, which are resistant to proteases and nucleases. Therefore, proteins inside HERDS could be protected from degrading enzymes. HERDS contain many RNA-associated autoantigens, such as the U1-70K protein ( Fig. 1 and ref [20] ) and the Sm antigen [54] , which are not degraded since they are still detectable by antibody probes. In addition, HERDS contain still detectable RNA [56] . Recently, it was found that proteins from the same nuclear structure show a different dynamical relocation during early apoptosis and cluster in different parts in the apoptotic cell [57] . The morphology of HERDS shown by electron microscopy shows the possible existence of specific domains inside HERDS (unpublished personal observations). However, data on the contents and mechanism leading to the formation of HERDS are scarce. One can imagine that HERDS have a different composition in different types of cells or under different conditions. In addition, the composition of HERDS might be different between normal and lupus situations.
Release into apoptotic microparticles and encounter with the immune system
After the formation of HERDS and the condensation of chromatin, these structures are partially or completely relocated to blebs on the cell surface. This relocation is dependent on the kinase ROCKI, which phosphorylates myosin and regulates the formation of surface blebs [58] . Transglutaminase activity has been found on sites of the cell membrane where apoptotic blebs are formed [59] . Transglutaminase is an enzyme that cross-links proteins and might therefore be involved in the clustering of proteins in structures like HERDS. Moreover, transglutaminase 2-deficient cells show a leakage of intracellular proteins [38] . The formation of apoptotic blebs seems to be a universal feature of apoptosis for many cells, although a different blebbing between adherent cells and cells growing in suspension has been described [60] . In addition, the formation of different kinds of blebs for one single cell has been found [8] . Thus, it was shown that two populations of surface blebs exist on keratinocytes, where proteins from the endoplasmic reticulum, ribosomes and the RNP Ro52 relocate to the small blebs while chromatin, Ro60, La and snRNPs relocate to the larger blebs [8] . Autoantigens are exposed on the outside of apoptotic blebs and can be bound by autoantibodies [61, 62] . Early during apoptosis, apoptotic blebs release from the apoptotic cell as apoptotic microparticles leaving the apoptotic cell body [63] . However, a detailed characterization of apoptotic blebs/microparticles for their contents and their stability is lacking so far. Importantly, most studies describe apoptotic cells that are obtained by low-speed centrifugation of cell cultures. When this method is applied apoptotic microparticles are lost, and their effect is therefore not taken into account.
The recognition of apoptotic cells by the immune system has been described extensively [64] . Generally, it is considered that apoptotic cells do not induce a proinflammatory response or even induce tolerance [1] and necrosis results in activation of the immune system. However, the story is not black and white, since apoptotic cells can propagate an immune response [65] . The activation of the immune system depends partly on the release of a recently identified class of molecules, the alarmins [1, 66] . These molecules which have their 'normal' function inside the cell, can also act as a cytokine when released from the cell. In general, apoptotic cells have several mechanisms to keep alarmins inside the cell and prevent the activation of the immune system. These mechanisms are still mostly unexplored, but studies on the classic alarmin HMGB1 have revealed some important information. HMGB1 is a protein involved in bending of dsDNA, but can be released from necrotic cells and activate immune cells by binding to receptor of advanced glycosylation products (RAGE) or Toll-like receptor (TLR)-4 [65] . In apoptotic cells HMGB1 is kept inside by binding to hypoacetylated chromatin [67] . However, apoptotic cells do release (some) HMGB1 [68, 69] , which is rendered inactive by reactive oxygen species originating from mitochrondria [69] . Very late apoptotic cells release chromatin particles, which contain HMGB1 that can activate immune cells [70] . Interestingly, chromatin isolated from the circulation of SLE patients is bound to HMGB1. In addition, HERDS might contain danger signals able to activate the immune system. Recently, a new potential alarmin present in a RNAassociated complex, i.e. SAP130 which is associated with the U2 snRNP particle, was identified [71] . This molecule could bind and activate marophages via the socalled Mincle receptor, a new member of the C-type lectin family. In addition, the RNA component of the U1 snRNP particle is able to activate TLR-7 [72, 73] . In conclusion, chromatin and HERDS bound to danger molecules might increase the potency of apoptotic microparticles to induce an autoimmune response. Indeed, the activation of DCs by apoptotic bodies has been documented [74] . However, the mechanism leading to activation is not clear. 
Summary
Apoptotic cells should not induce an immune response under normal circumstances; however, this seems exactly what happens during the autoimmune disease SLE. Why apoptotic cells or proteins derived from apoptotic cells are able to induce an immune response during SLE remains largely unexplained. As summarized in this review, an increasing amount of evidence points to the apoptotic processing of proteins, particular of nuclear origin, as an important event (Fig. 2) . Post-translational modifications of nuclear proteins might lead to the exposure of neo-epitopes. Subsequently, modified nuclear proteins are reorganized together with danger molecules (such as alarmins) into condensed clusters, which may protect them from nucleases and proteases. Apoptotic clusters are relocated to apoptotic blebs, which can be released as microparticles when apoptotic cells are not removed in time. Antigen-presenting cells are able to process these structures in a pro-inflammatory context and activate the immune system to produce autoantibodies against apoptotically-processed nuclear proteins. Future research has to fill in many of the gaps in this proposed mechanism and may lead to the development of new therapeutical approaches by preventing the activation of the immune system by modified apoptotic structures. Fig. 1 . Overview of the apoptosis-associated modifications of the U1-70K protein as described in ref 20 . Phosphorylation of Ser140 increases (1), followed by a simultaneous cleavage of the protein by caspase-3 (2) and dephosphorylation of other residues by protein phosphatase 1 (3). The modified protein is clustered in HERDS (4) and released in apoptotic microparticles. 
